Elidel and Hodgkin's lymphoma - a phase IV clinical study of FDA data

Summary:

Hodgkin's lymphoma is found among people who take Elidel, especially for people who are female, 30-39 old, have been taking the drug for 1 - 2 years.

The phase IV clinical study analyzes which people take Elidel and have Hodgkin's lymphoma. It is created by eHealthMe based on reports of 4,352 people who have side effects when taking Elidel from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Aug, 20, 2022

4,352 people reported to have side effects when taking Elidel.
Among them, 177 people (4.07%) have Hodgkin's lymphoma.


What is Elidel?

Elidel has active ingredients of pimecrolimus. It is often used in eczema. eHealthMe is studying from 4,190 Elidel users for its effectiveness, alternative drugs and more.

What is Hodgkin's lymphoma?

Hodgkin's lymphoma (cancer originating from white blood cells) is found to be associated with 912 drugs and 558 conditions by eHealthMe.

Number of Elidel and Hodgkin's lymphoma reports submitted per year:

Could Elidel cause Hodgkin's lymphoma?

Time on Elidel when people have Hodgkin's lymphoma *:

Click here to view

Gender of people who have Hodgkin's lymphoma when taking Elidel*:

Click here to view

Age of people who have Hodgkin's lymphoma when taking Elidel *:

Click here to view

Common drugs people take besides Elidel *:

Click here to view

Common side effects people have besides Hodgkin's lymphoma *:

Click here to view

Common conditions people have *:

Click here to view

* Approximation only. Some reports may have incomplete information.

Do you take Elidel and have Hodgkin's lymphoma?

Check whether Hodgkin's lymphoma is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

How severe was Hodgkin's lymphoma and when was it recovered:

Expand to all the drugs that have ingredients of pimecrolimus:

Alternative drugs to, pros and cons of Elidel:

Common Elidel side effects:

Browse all side effects of Elidel:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Hodgkin's lymphoma treatments and more:

COVID vaccines that are related to Hodgkin's lymphoma:

Common drugs associated with Hodgkin's lymphoma:

All the drugs that are associated with Hodgkin's lymphoma:

Common conditions associated with Hodgkin's lymphoma:

All the conditions that are associated with Hodgkin's lymphoma:

How the study uses the data?

The study uses data from the FDA. It is based on pimecrolimus (the active ingredients of Elidel) and Elidel (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: